Home
LiteratureArticle Details
PMID: 16633057
Published · ppublish
English
Comparative Study
Letter
Rifaximin for active ulcerative colitis.
Abstract
暂无摘要
MeSH Terms
Adult
Aged
Colitis, Ulcerative/drug therapy
Dose-Response Relationship, Drug
Female
Follow-Up Studies
Gastrointestinal Agents/administration & dosage,therapeutic use
Humans
Male
Middle Aged
Remission Induction
Rifamycins/administration & dosage,therapeutic use
Rifaximin
Treatment Outcome
Chemicals
Gastrointestinal Agents
Rifamycins
Rifaximin
Article Info
Journal
Inflammatory bowel diseases
Abbr.
Inflamm Bowel Dis
ISSN
1078-0998
Published
2006-04-00
Pages
335
Language
English
Region
England
NLM ID
9508162
Subset
IM
Analysis Services
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
